This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...

Google Research and Google DeepMind recently released a paper announcing the creation of a new LLM for drug discovery and therapeutic development dubbed Tx-LLM, fine-tuned from PaLM-2. Tx-LLM utilizes ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...

Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...